Alzheimer’s Tau protein forms toxic complexes with cell membranes
Researchers identify the sequence and structural factors that drive Tau interaction with membranes...
List view / Grid view
Researchers identify the sequence and structural factors that drive Tau interaction with membranes...
Researchers have identified a new protective function for a brain protein genetically linked to Alzheimer's...
Brain changes linked to memory loss may provide a new focus for exploring ways to treat or prevent dementia...
Researchers have built a synthetic genetic tool yTRAP to quantitatively sense, measure and manipulate protein aggregation in live cells...
Researchers identify binding site on the amyloid beta peptide that could facilitate better drugs to treat the disease...
Researchers have performed meta-analysis of neurological and neurodegenerative diseases and created an atlas of how cell characteristics are linked to their genotype...
Micron-level, 3-D visualisation of protein deposits found in Alzheimer's disease could speed development of new treatments...
Scientists have identified that a mutation in the gene TREM2, can substantially raise a person’s risk of Alzheimer’s disease...
Researchers have found that polymer and hybrid silica-coated microcapsules are efficient in genome-editing...
Researchers have discovered that impairing a critical partnership between brain cells can lead to neurodegeneration...
Researchers have identified that the presence of ApoE4 exacerbates the brain damage caused by toxic tangles of tau protein...
Researchers have displayed structural details of amyloid structures which may answer many questions on the growth of harmful deposits...
Alzheimer’s disease (AD) is the most prevalent form of dementia.1 The common (>95% of cases) slow-developing form of the ailment is known as late-onset AD (LOAD) or sporadic AD (SAD). The rare (
Researchers have identified a promising new avenue to explore in the search for stroke treatments...
Included in this issue: The importance of industry partnerships; Calcilytics as potential novel therapeutic treatments to halt Alzheimer's disease; Accelerating neuroscience research with flow cytometry...